DAMORA THERAPEUTICS INC (DMRA) — insider trading
Health Care · NASDAQ
DAMORA THERAPEUTICS INC (DMRA) has 11 reported SEC Form 4 insider transactions in our data, including 1 open-market sale among the most recent 11 (latest 2026-07-06).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-07-06 | Winslow Garrett | Officer (General Counsel) | Open-market sale | 245 | $29.98 | $7.3K | Form 4 |
| 2026-07-03 | Winslow Garrett | Officer (General Counsel) | Option exercise / conversion (derivative) | 680 | $0.00 | $0 | Form 4 |
| 2026-07-03 | Winslow Garrett | Officer (General Counsel) | Option exercise / conversion | 680 | — | — | Form 4 |
| 2026-03-30 | Jarrett Jennifer | Director, Officer (See Remarks) | Grant / award / vesting (derivative) | 1,500,000 | $0.00 | $0 | Form 4 |
| 2026-03-30 | Jarrett Jennifer | Director, Officer (See Remarks) | Grant / award / vesting | 500,000 | $0.00 | $0 | Form 4 |
| 2026-03-23 | Bruno Julianne | Director | Grant / award / vesting (derivative) | 37,313 | $0.00 | $0 | Form 4 |
| 2026-03-23 | CAIN CHRISTOPHER W. | Director | Grant / award / vesting (derivative) | 37,313 | $0.00 | $0 | Form 4 |
| 2026-03-23 | Fairmount Funds Management LLC; Fairmount Healthcare Fund II L.P.; Fairmount Healthcare Co-Invest V L.P.; Kiselak Tomas; Harwin Peter Evan | Director, 10% owner | Grant / award / vesting (derivative) | 37,313 | $0.00 | $0 | Form 4 |
| 2026-03-23 | Landsittel Michael | Director | Grant / award / vesting (derivative) | 37,313 | $0.00 | $0 | Form 4 |
| 2026-03-23 | Turtle Cameron | Director | Grant / award / vesting (derivative) | 37,313 | $0.00 | $0 | Form 4 |
| 2026-03-23 | Winslow Garrett | Officer (General Counsel) | Grant / award / vesting (derivative) | 250,000 | $0.00 | $0 | Form 4 |
Ask the chat about DMRA's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: DAMORA THERAPEUTICS INC (DMRA).
Last updated 2026-07-06 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.